These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 11777570

  • 1. Culture of the marine cyanobacterium, Lyngbya majuscula (Oscillatoriaceae), for bioprocess intensified production of cyclic and linear lipopeptides.
    Burja AM, Abou-Mansour E, Banaigs B, Payri C, Burgess JG, Wright PC.
    J Microbiol Methods; 2002 Feb; 48(2-3):207-19. PubMed ID: 11777570
    [Abstract] [Full Text] [Related]

  • 2. Apramides A-G, novel lipopeptides from the marine cyanobacterium Lyngbya majuscula.
    Luesch H, Yoshida WY, Moore RE, Paul VJ.
    J Nat Prod; 2000 Aug; 63(8):1106-12. PubMed ID: 10978206
    [Abstract] [Full Text] [Related]

  • 3. Morphological, chemical, and genetic diversity of tropical marine cyanobacteria Lyngbya spp. and Symploca spp. (Oscillatoriales).
    Thacker RW, Paul VJ.
    Appl Environ Microbiol; 2004 Jun; 70(6):3305-12. PubMed ID: 15184125
    [Abstract] [Full Text] [Related]

  • 4. Carmabins A and B, new lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula.
    Hooper GJ, Orjala J, Schatzman RC, Gerwick WH.
    J Nat Prod; 1998 Apr; 61(4):529-33. PubMed ID: 9584405
    [Abstract] [Full Text] [Related]

  • 5. New lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula.
    Jiménez JI, Scheuer PJ.
    J Nat Prod; 2001 Feb; 64(2):200-3. PubMed ID: 11430000
    [Abstract] [Full Text] [Related]

  • 6. Curacin D, an antimitotic agent from the marine cyanobacterium Lyngbya majuscula.
    Márquez B, Verdier-Pinard P, Hamel E, Gerwick WH.
    Phytochemistry; 1998 Dec; 49(8):2387-9. PubMed ID: 9887531
    [Abstract] [Full Text] [Related]

  • 7. Antillatoxin B, a neurotoxic lipopeptide from the marine cyanobacterium Lyngbya majuscula.
    Nogle LM, Okino T, Gerwick WH.
    J Nat Prod; 2001 Jul; 64(7):983-5. PubMed ID: 11473443
    [Abstract] [Full Text] [Related]

  • 8. Palmyramide A, a cyclic depsipeptide from a Palmyra Atoll collection of the marine cyanobacterium Lyngbya majuscula.
    Taniguchi M, Nunnery JK, Engene N, Esquenazi E, Byrum T, Dorrestein PC, Gerwick WH.
    J Nat Prod; 2010 Mar 26; 73(3):393-8. PubMed ID: 19839606
    [Abstract] [Full Text] [Related]

  • 9. Genomic insights into the physiology and ecology of the marine filamentous cyanobacterium Lyngbya majuscula.
    Jones AC, Monroe EA, Podell S, Hess WR, Klages S, Esquenazi E, Niessen S, Hoover H, Rothmann M, Lasken RS, Yates JR, Reinhardt R, Kube M, Burkart MD, Allen EE, Dorrestein PC, Gerwick WH, Gerwick L.
    Proc Natl Acad Sci U S A; 2011 May 24; 108(21):8815-20. PubMed ID: 21555588
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the hupSL operon of the nonheterocystous cyanobacterium Lyngbya majuscula CCAP 1446/4: regulation of transcription and expression under a light-dark regimen.
    Leitão E, Oxelfelt F, Oliveira P, Moradas-Ferreira P, Tamagnini P.
    Appl Environ Microbiol; 2005 Aug 24; 71(8):4567-76. PubMed ID: 16085850
    [Abstract] [Full Text] [Related]

  • 11. Visualizing the spatial distribution of secondary metabolites produced by marine cyanobacteria and sponges via MALDI-TOF imaging.
    Esquenazi E, Coates C, Simmons L, Gonzalez D, Gerwick WH, Dorrestein PC.
    Mol Biosyst; 2008 Jun 24; 4(6):562-70. PubMed ID: 18493654
    [Abstract] [Full Text] [Related]

  • 12. Isolation, structure determination, and biological activity of Lyngbyabellin A from the marine cyanobacterium lyngbya majuscula.
    Luesch H, Yoshida WY, Moore RE, Paul VJ, Mooberry SL.
    J Nat Prod; 2000 May 24; 63(5):611-5. PubMed ID: 10843570
    [Abstract] [Full Text] [Related]

  • 13. Use of superoxide as an electron shuttle for iron acquisition by the marine cyanobacterium Lyngbya majuscula.
    Rose AL, Salmon TP, Lukondeh T, Neilan BA, Waite TD.
    Environ Sci Technol; 2005 May 15; 39(10):3708-15. PubMed ID: 15952376
    [Abstract] [Full Text] [Related]

  • 14. Anti-Infective Secondary Metabolites of the Marine Cyanobacterium Lyngbya Morphotype between 1979 and 2022.
    Youssef DTA, Mufti SJ, Badiab AA, Shaala LA.
    Mar Drugs; 2022 Dec 07; 20(12):. PubMed ID: 36547915
    [Abstract] [Full Text] [Related]

  • 15. Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula.
    McPhail KL, Correa J, Linington RG, Gonzalez J, Ortega-Barría E, Capson TL, Gerwick WH.
    J Nat Prod; 2007 Jun 07; 70(6):984-8. PubMed ID: 17441769
    [Abstract] [Full Text] [Related]

  • 16. Global phylogeography of toxic cyanobacteria Moorea producens reveals distinct genetic partitioning influenced by Proterozoic glacial cycles.
    Curren E, Leong SCY.
    Harmful Algae; 2019 Jun 07; 86():10-19. PubMed ID: 31358269
    [Abstract] [Full Text] [Related]

  • 17. Immunolocalization of the uptake hydrogenase in the marine cyanobacterium Lyngbya majuscula CCAP 1446/4 and two Nostoc strains.
    Seabra R, Santos A, Pereira S, Moradas-Ferreira P, Tamagnini P.
    FEMS Microbiol Lett; 2009 Mar 07; 292(1):57-62. PubMed ID: 19222582
    [Abstract] [Full Text] [Related]

  • 18. Aquatic Antagonists: Seaweed Dermatitis (Lyngbya majuscula).
    Hill KL, Fulton HM, McGovern TW.
    Cutis; 2024 May 07; 113(5):E38-E40. PubMed ID: 39042127
    [Abstract] [Full Text] [Related]

  • 19. Transcription and regulation of the hydrogenase(s) accessory genes, hypFCDEAB, in the cyanobacterium Lyngbya majuscula CCAP 1446/4.
    Ferreira D, Leitão E, Sjöholm J, Oliveira P, Lindblad P, Moradas-Ferreira P, Tamagnini P.
    Arch Microbiol; 2007 Dec 07; 188(6):609-17. PubMed ID: 17639348
    [Abstract] [Full Text] [Related]

  • 20. Yanucamides A and B, two new depsipeptides from an assemblage of the marine cyanobacteria Lyngbya majuscula and Schizothrix species.
    Sitachitta N, Williamson RT, Gerwick WH.
    J Nat Prod; 2000 Feb 07; 63(2):197-200. PubMed ID: 10691708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.